Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.28 is 25% below its 5-year average of 11.02, around the middle of its 5-year range (1.50–18.97).
As of the fiscal period ended Tuesday, June 30, 2026. 0.16% below its 12-month average of 8.29.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.28.
QUICK RATIO (ACID-TEST)
8.28
QUICK RATIO (ACID-TEST) AVG TTM
8.29
QUICK RATIO (ACID-TEST) AVG 3Y
9.45
QUICK RATIO (ACID-TEST) AVG 5Y
11.02
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.16%
CURRENT VS 3Y AVG
-12.42%
CURRENT VS 5Y AVG
-24.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 613 covered companies
CURRENT VS SECTOR MEDIAN
+176.93%
vs the sector median at left
Century Therapeutics, Inc.
Market Cap
$255.08M
Quick Ratio (Acid-Test)
8.28
TTM Avg
8.29
3Y Avg
9.45
5Y Avg
11.02
Market Cap
$256.48M
Quick Ratio (Acid-Test)
3.19
TTM Avg
3.85
3Y Avg
4.21
5Y Avg
4.14
Market Cap
$258.00M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.36
3Y Avg
5.78
5Y Avg
8.29
Market Cap
$258.34M
Quick Ratio (Acid-Test)
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$258.48M
Quick Ratio (Acid-Test)
4.46
TTM Avg
8.30
3Y Avg
6.73
5Y Avg
6.78
Market Cap
$259.30M
Quick Ratio (Acid-Test)
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$250.48M
Quick Ratio (Acid-Test)
13.89
TTM Avg
8.37
3Y Avg
7.38
5Y Avg
15.00
Market Cap
$243.81M
Quick Ratio (Acid-Test)
2.69
TTM Avg
2.01
3Y Avg
1.61
5Y Avg
1.29
Market Cap
$243.64M
Quick Ratio (Acid-Test)
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $255.08M | 8.28 | 8.29 | 9.45 | 11.02 |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.48M | 3.19 | 3.85 | 4.21 | 4.14 |
| AC Immune S.A. (ACIU)vs › | $258.00M | 0.93 | 1.36 | 5.78 | 8.29 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $258.34M | 15.82 | 24.04 | 14.70 | 12.06 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $258.48M | 4.46 | 8.30 | 6.73 | 6.78 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 16.00 | 13.11 | 8.33 | 7.81 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | 13.89 | 8.37 | 7.38 | 15.00 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | 2.69 | 2.01 | 1.61 | 1.29 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.64M | 1.54 | 1.17 | 19.33 | 29.22 |
| Invivyd, Inc. (IVVD)vs › | $241.61M | 5.86 | 4.06 | 6.91 | 7.76 |
Quick Ratio
8.28
Excludes inventory
Current Ratio
8.28
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.28 |
| 2026-03-31 | 10.25 |
| 2025-12-31 | 5.97 |
| 2025-09-30 | 6.25 |
| 2025-06-30 | 10.72 |
| 2025-03-31 | 11.70 |
| 2024-12-31 | 1.50 |
| 2024-09-30 | 10.39 |
| 2024-06-30 | 10.62 |
| 2024-03-31 | 12.44 |
| 2023-12-31 | 9.92 |
| 2023-09-30 | 8.50 |
| 2023-06-30 | 8.42 |
| 2023-03-31 | 9.24 |
| 2022-12-31 | 10.72 |
| 2022-09-30 | 13.44 |
| 2022-06-30 | 17.79 |
| 2022-03-31 | 16.62 |
| 2021-12-31 | 14.57 |
| 2021-09-30 | 15.12 |
| 2021-06-30 | 18.97 |
| 2021-03-31 | 14.35 |
| 2020-12-31 | 6.51 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
